Issue 1/2013
Content (27 Articles)
Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
Svein Solheim, Ingebjørg Seljeflot, Ketil Lunde, Vibeke Bratseth, Svend Aakhus, Kolbjørn Forfang, Harald Arnesen
Purification and characterization of mutant miniPlasmin for thrombolytic therapy
Xiaotao Lin, Yan Wang, Yanwen Zhang, Bing Huang, James J Lin, Scott J Hallock, Hong Yu, Hongwei Shao, Jing Yan, Bo Huang, Xuejun C Zhang, Wei Cao, Xueming Xu, Xinli Lin
Postpartum deep vein thrombosis and pulmonary embolism in twin pregnancy: undertaking of clinical symptoms leading to massive complications
Leslie Fiengo, Federico Bucci, Gregorio Patrizi, Domenico Giannotti, Adriano Redler
Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study
Michael Nagler, Lucas M Bachmann, Lorenzo Alberio, Anne Angelillo-Scherrer, Lars M Asmis, Wolfgang Korte, Adriana Mendez, Guido Reber, Hans Stricker, Dimitrios A Tsakiris, Walter A Wuillemin
Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort study
Takahiro Kato, Takamasa Sakai, Miki Kato, Mao Hagihara, Takaaki Hasegawa, Katsuhiko Matsuura, Takashi Nakagawa
Giant left atrium associated with massive thrombus formation
Ahmad K Darwazah, Hamdy El Sayed
Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia
Margaret M Prechel, Jeanine M Walenga
Results expression for tests used to measure the anticoagulant effect of new oral anticoagulants
Armando Tripodi
Correction of microplate location effects improves performance of the thrombin generation test
Yideng Liang, Samuel A Woodle, Alexey M Shibeko, Timothy K Lee, Mikhail V Ovanesov
Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism
Martin H Prins, Anthonie WA Lensing
New oral anticoagulants: discussion on monitoring and adherence should start now!
Hugo ten Cate
Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring
Wolfgang Mueck, Stephan Schwers, Jan Stampfuss
Laboratory assessment of rivaroxaban: a review
Meyer Michel Samama, Geneviève Contant, Theodore E Spiro, Elisabeth Perzborn, Lena Le Flem, Céline Guinet, Yves Gourmelin, Gabriele Rohde, Jean-Luc Martinoli
Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort
Fernando Javier Vázquez, María Lourdes Posadas-Martínez, Jimena Vicens, Fernán González Bernaldo de Quirós, Diego Hernán Giunta
Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model
Léon Nshimyumukiza, Julie Duplantie, Mathieu Gagnon, Xavier Douville, Diane Fournier, Carmen Lindsay, Marc Parent, Alain Milot, Yves Giguère, Christian Gagné, François Rousseau, Daniel Reinharz
Concept of a point of care test to detect new oral anticoagulants in urine samples
Job Harenberg, Sandra Krämer, Shanshan Du, Christel Weiss, Roland Krämer
The new oral anti-coagulants and the phase 3 clinical trials - a systematic review of the literature
Faryal Tahir, Haris Riaz, Talha Riaz, Maaz B Badshah, Irbaz B Riaz, Ameer Hamza, Hafsa Mohiuddin
Activated protein C resistance in Behcet’s disease
Hoda Abdel Badaee, Amr Edrees, Sherif Amin, Maher El Amir, Gaafar Ragab
Protein-C deficiency presenting as pulmonary embolism and myocardial infarction in the same patient
Syed Maqbool, Vishal Rastogi, Ashok Seth, Satbir Singh, Vijay Kumar, Arif Mustaqueem
Isolated pancreatic heamorrhage in association with anticoagulation
Keith Chiu, Abdul Razack, Anthony Maraveyas
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
Martin H Prins, Anthonie WA Lensing, Rupert Bauersachs, Bonno van Bellen, Henri Bounameaux, Timothy A Brighton, Alexander T Cohen, Bruce L Davidson, Hervé Decousus, Gary E Raskob, Scott D Berkowitz, Philip S Wells
VacA, the vacuolating cytotoxin of Helicobacter pylori, binds to multimerin 1 on human platelets
Kaneo Satoh, Toshiya Hirayama, Katsuhiro Takano, Katsue Suzuki-Inoue, Tadashi Sato, Masato Ohta, Junko Nakagomi, Yukio Ozaki
Thrombin generation as marker to estimate thrombosis risk in patients with abnormal test results in lupus anticoagulant routine diagnostics
Klas Boeer, Leonid Cuznetov, Wolfgang Loesche
Resolution of left atrial appendage thrombus with apixaban
Tohru Kawakami, Hiroko Kobayakawa, Hiroyoshi Ohno, Nobukiyo Tanaka, Hiroki Ishihara
Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies
Yuqi Wang, Chen Wang, Zhong Chen, Jiwei Zhang, Zhihong Liu, Bi Jin, Kejing Ying, Changwei Liu, Yuxia Shao, Zhicheng Jing, Isabelle Ling Meng, Martin H Prins, Ákos F Pap, Katharina Müller, Anthonie WA Lensing
Main considerable factors for correct laboratory test interpretation under DOA treatment
Helen Mani, Edelgard Lindhoff-Last
Practical management of patients on apixaban: a consensus guide
Christopher Ward, Greg Conner, Geoffrey Donnan, Alexander Gallus, Simon McRae